STATE OF WISCONSIN INVESTMENT BOARD - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$447,646
-16.1%
49,084
-2.7%
0.00%0.0%
Q2 2023$533,465
-18.4%
50,422
-5.7%
0.00%
-50.0%
Q1 2023$654,097
-2.6%
53,483
-1.1%
0.00%0.0%
Q4 2022$671,294
-14.6%
54,093
-6.0%
0.00%0.0%
Q3 2022$786,000
-29.3%
57,566
-5.1%
0.00%
-33.3%
Q2 2022$1,112,000
-18.0%
60,645
-28.1%
0.00%0.0%
Q1 2022$1,356,000
+14.9%
84,3000.0%0.00%
+50.0%
Q4 2021$1,180,000
-25.3%
84,3000.0%0.00%
-33.3%
Q3 2021$1,579,000
-10.2%
84,3000.0%0.00%
-25.0%
Q2 2021$1,758,000
-26.2%
84,3000.0%0.00%
-20.0%
Q1 2021$2,383,000
-14.6%
84,300
-1.4%
0.01%
-16.7%
Q4 2020$2,792,000
+7.1%
85,500
+0.5%
0.01%
-14.3%
Q3 2020$2,607,000
+157.9%
85,100
+37.3%
0.01%
+133.3%
Q2 2020$1,011,000
+91.8%
62,000
+17.0%
0.00%
+50.0%
Q1 2020$527,000
-11.7%
53,000
+22.1%
0.00%
+100.0%
Q4 2019$597,000
-9.3%
43,4000.0%0.00%
-50.0%
Q3 2019$658,000
-18.5%
43,400
+5.9%
0.00%0.0%
Q2 2019$807,000
+21.4%
41,000
+2.2%
0.00%0.0%
Q1 2019$665,000
+63.4%
40,100
+38.3%
0.00%
+100.0%
Q4 2018$407,000
-10.2%
29,000
+12.0%
0.00%0.0%
Q3 2018$453,000
+126.5%
25,900
+135.5%
0.00%0.0%
Q2 2018$200,000
-2.9%
11,0000.0%0.00%0.0%
Q1 2018$206,000
+22.6%
11,0000.0%0.00%
Q4 2017$168,000
+2.4%
11,0000.0%0.00%
Q3 2017$164,000
+60.8%
11,0000.0%0.00%
Q2 2017$102,00011,0000.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 206,307$3,363,00011.31%
Foresite Capital Management IV, LLC 1,307,982$21,320,00010.39%
EcoR1 Capital, LLC 4,608,529$75,119,0005.55%
Prosight Management, LP 685,000$11,166,0004.79%
ACUTA CAPITAL PARTNERS, LLC 872,500$14,222,0004.11%
BVF INC/IL 2,775,882$45,247,0002.79%
VR Adviser, LLC 575,000$9,373,0002.24%
ALETHEA CAPITAL MANAGEMENT, LLC 216,171$3,524,0002.06%
DAFNA Capital Management LLC 294,260$4,796,0001.38%
Vivo Capital, LLC 1,050,000$17,115,0001.23%
View complete list of KURA ONCOLOGY INC shareholders